Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women

Maturitas

Volumn 57, Issue 4, 2007, Pages 347-360

  Haren, Matthew T ^a,b   Malmstrom, Theodore K ^a   Banks, William A ^a,b   Patrick, Ping ^a   Miller, Douglas K ^c   Morley, John E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

Author keywords

African American; Dehydroepiandrosterone; Disability; Menopause; Mood; Oestrogen; Physical function; Testosterone; Women

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE RECEPTOR; ESTRADIOL; GLUCOSE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; LEPTIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; BLOOD ANALYSIS; BODY COMPOSITION; CORRELATION ANALYSIS; DEPRESSION; DISABILITY; ESTROGEN THERAPY; FEMALE; HAND GRIP; HEALTH STATUS; HORMONE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MENOPAUSE; MIDDLE AGED; MUSCLE STRENGTH; NEUROPSYCHOLOGY; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RANDOM SAMPLE; STATISTICAL MODEL; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

AFRICAN AMERICANS; AGED; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSION; DISABILITY EVALUATION; ESTRADIOL; FEMALE; HEALTH STATUS; HUMANS; LINEAR MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE STRENGTH; TESTOSTERONE;

EID: 34447271001     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.03.003     Document Type: Article

References (35)

1. Davison S, et al., Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab, 2005.
2. Morley J.E., and Perry III H.M. Androgens and women at the menopause and beyond. J Gerontol A Biol Sci Med Sci 58 5 (2003) M409-M416
3. Dennerstein L., et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96 3 (2000) 351-358
4. Santoro N., et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 90 8 (2005) 4836-4845
5. Barrett-Connor E., et al. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc 47 6 (1999) 685-691
6. Miller D.K., et al. Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc 52 5 (2004) 741-748
7. Miller D.K., et al. Inner city, middle-aged African Americans have excess frank and subclinical disability. J Gerontol A Biol Sci Med Sci 60 2 (2005) 207-212
8. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 3 (1969) 179-186
9. Nagi S.Z. An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc 54 4 (1976) 439-467
10. Dipietro L., et al. A survey for assessing physical activity among older adults. Med Sci Sports Exerc 25 5 (1993) 628-642
11. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 3 (1975) 189-198
12. Anthony J.C., et al. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med 12 2 (1982) 397-408
13. Kohout F.J., et al. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 5 2 (1993) 179-193
14. Greenlief C.L., Margolis R.B., and Erker G.J. Application of the trail making test in differentiating neuropsychological impairment of elderly persons. Percept Mot Skills 61 3 Pt 2 (1985) 1283-1289
15. Crowe S.F. The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the Trail Making Test. J Clin Psychol 54 5 (1998) 585-591
16. Arbuthnott K., and Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 22 4 (2000) 518-528
17. Orentreich N., et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59 3 (1984) 551-555
18. Labrie F., et al. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 82 8 (1997) 2403-2409
19. Burger H.G., et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 8 (2000) 2832-2838
20. Rosner W., et al. Androgens, estrogens, and second messengers. Steroids 63 5/6 (1998) 278-281
21. Kraemer G.R., et al. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin. Fertil Steril 79 3 (2003) 534-542
22. Xu A., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280 18 (2005) 18073-18080
23. Goodman-Gruen D., and Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diab Care 20 4 (1997) 645-649
24. Sutton-Tyrrell K., et al. Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111 10 (2005) 1242-1249
25. Ducluzeau P.H., et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 8 (2003) 3626-3631
26. Beer N.A., et al. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. J Clin Endocrinol Metab 76 6 (1993) 1464-1469
27. Ueshiba H., Tsuboi K., and Miyachi Y. Effects of amlodipine on serum levels of adrenal androgens and insulin in hypertensive men with obesity. Horm Metab Res 33 3 (2001) 167-169
28. Ueshiba H., and Miyachi Y. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients. Intern Med 43 7 (2004) 561-565
29. Maccario M., et al. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension. J Endocrinol Invest 21 1 (1998) 56-63
30. Ram P.A., and Waxman D.J. Dehydroepiandrosterone 3 beta-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca(2+)-channel blockers. Biochem J 301 Pt 3 (1994) 753-758
31. Zhang H., et al. Effect of nicardipine, a calcium antagonist, on induction of peroxisomal enzymes by dehydroepiandrosterone sulfate in cultured rat hepatocytes. J Toxicol Sci 21 4 (1996) 235-241
32. Papalia M.A., and Davis S.R. What is the rationale for androgen therapy for women?. Treat Endocrinol 2 2 (2003) 77-84
33. Arlt W. Androgen therapy in women. Eur J Endocrinol 154 1 (2006) 1-11
34. Barnhart K.T., et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84 11 (1999) 3896-3902
35. Finckh A., et al. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 32 7 (2005) 1336-1340